Hong Kong stock market anomaly | Sanse Pharmaceutical (01530.HK) rises more than 3%, SSGJ-707 partnering with Pfizer to go overseas, significant potential for overseas valuation increase.

According to the Securities Times APP, Sansei Pharmaceuticals (01530.HK) has surged by more than 3%, with a cumulative increase of over 1.6 times in two months. As of the time of publication, it has risen by 2.82% to 32.8 Hong Kong dollars, with a trading volume of 404 million Hong Kong dollars.